| Authors: |
Gopalsamy A; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Narayanan A; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Liu S; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Parikh MD; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Kyne RE Jr; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Fadeyi O; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Tones MA; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Cherry JJ; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Nabhan JF; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., LaRosa G; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Petersen DN; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Menard C; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Foley TL; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Noell S; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Ren Y; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Loria PM; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Maglich-Goodwin J; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Rong H; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States., Jones LH; Medicine Design and ‡Rare Disease Research Unit, #Pharmacokinetics and Drug Metabolism, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.; Medicine Design and †Primary Pharmacology Group, Pfizer , Eastern Point Road, Groton, Connecticut 06340, United States. |